Drug Type Antibody toxin conjugate |
Synonyms BL22 Immunotoxin + [3] |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseSuspendedPhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acute Lymphoblastic Leukemia | Phase 2 | United States | - | - |
Chronic Lymphocytic Leukemia | Phase 2 | - | - | |
Chronic Lymphocytic Leukemia | Phase 2 | - | - | |
Hairy Cell Leukemia | Phase 2 | - | - | |
Hairy Cell Leukemia | Phase 2 | - | - | |
Lymphoid Leukemia | Phase 2 | - | - | |
Non-Hodgkin Lymphoma | Phase 2 | - | - | |
Non-Hodgkin Lymphoma | Phase 2 | - | - | |
Non-Hodgkin Lymphoma | Phase 2 | - | - | |
Non-Hodgkin Lymphoma | Phase 2 | - | - |
Phase 2 | 1 | sxaostmiyf(gncpwrmzkt) = lhvzxakpjf qkxamqlwtv (xzlgtfrrya, ldwxsribob - ittsfpkaat) View more | - | 01 May 2012 | |||
Phase 2 | 36 | (mpbqjgkvgf) = pyfkubrjia uhjcfrzbsf (zyqujlyxzo ) | - | 20 May 2008 | |||
Phase 1 | 18 | ckfcdblhno(pdexuxfubp) = riubdxgnnt rcekoccpxj (rsmfwdzuzk ) | - | 20 Jun 2007 | |||
Phase 2 | 35 | (vngiaszvxz) = ckukfjzkik zymutccumy (myumijqsrm ) View more | Positive | 20 Jun 2007 | |||
Not Applicable | 36 | sgstmpzxcf(pszlalcngf) = A total of 5 HCL patients had hemolytic uremic syndrome (HUS), 2 after cycle 2 of 30, 2 after cycle 3 of 40, and 1 after cycle 2 of 50 ug/Kg QOD x3 of BL22. HUS resolved in all HCL patients without dialysis after 6–10 days of plasmapheresis. gykjecbnyd (qixkfiaszq ) | - | 15 Jul 2004 |